BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2012
View Archived Issues
Korean researchers patent new fusion proteins for fibrosis
Read More
Epizyme designs novel EZH2 inhibitors
Read More
New double-stranded siNA molecules disclosed by Johns Hopkins University
Read More
Stem CentRx prepares novel modulators of ephrin-A
Read More
Antares Pharma reports data from actual human use study of Vibex methotrexate
Read More
Seattle Genetics and Millennium complete enrollment in phase III AETHERA trial
Read More
Novel hPASK inhibitors patented by Bioenergenix
Read More
Results from first-in-human trial of Dz13 reported
Read More
Minicircle plasmid DNA vector successfully treats liver disease in mice
Read More
Roche patents new inhibitors of Mdm2/p53
Read More
Oral FluCide candidates demonstrate efficacy in H3N2 influenza A virus model
Read More
MediBIC signs agreement with Virginia Commonwealth University for RSR-13
Read More
Cellceutix set to commence clinical trials with Kevetrin following IRB approval
Read More
NIH launches DEX-M74 trial for hereditary inclusion body myopathy
Read More
FDA advisory committee to review Ampligen NDA
Read More
Beta-amyloid 17 identified as a potential blood biomarker of early Alzheimer's disease
Read More
RXi Pharmaceuticals completes dosing in first phase I trial of RXI-109
Read More
Ohr Pharmaceutical commences phase II trial of squalamine eye drops in wet AMD
Read More
Vertex reports new data for two nucleotide analogues in patients with hepatitis C
Read More
Mallinckrodt enters definitive agreement to acquire CNS Therapeutics
Read More
Teijin Pharma describes novel anticoagulant molecules
Read More
biOasis presents preliminary toxicity results for BT-2111
Read More
Regeneron's Eylea receives second U.S. approval
Read More
Enrollment completed in phase II trial of novel therapeutic for critical limb ischemia
Read More
Navidea receives complete response letter from FDA regarding Lymphoseek NDA
Read More
Recruitment completed in phase III studies of nintedanib in IPF
Read More